» Authors » Cecilia Chaparro

Cecilia Chaparro

Explore the profile of Cecilia Chaparro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 1826
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Walti L, Ng C, Kaur S, Almansour S, Mazzulli T, Bitterman R, et al.
Clin Infect Dis . 2025 Feb; PMID: 39985813
Background: Hyperammonemia syndrome (HS) is a rare but potentially fatal complication of Lung Transplantation (LT). Optimal screening methods are unknown: Here we investigated serum ammonia screening (SAS) for HS and...
2.
Bitterman R, Soualhine H, Akochy P, Poirier C, Ferraro P, Kabbani D, et al.
Transpl Infect Dis . 2025 Feb; :e70003. PMID: 39964168
Background: Mycobacterium abscessus complex is known to cause life-threatening disease in lung transplantation (LT) recipients (LTRs). Therefore, many centers consider the presence of M. abscessus as a relative contraindication to...
3.
Nicholson J, Goldstein R, Nourouzpour S, Elangeswaran B, Munawar M, Wickerson L, et al.
Respir Med . 2025 Feb; 239:107982. PMID: 39921065
Background/rationale: Lung transplant (LTx) candidates with cystic fibrosis (CF) have ventilatory and musculoskeletal limitations and benefit from pulmonary rehabilitation (PR). Their training response has not been well characterized. The study...
4.
Rzepka A, Tile L, Chow C, McDonald-Blumer H, Chaparro C, Ridout R, et al.
J Heart Lung Transplant . 2025 Jan; PMID: 39837402
Bone health after lung transplantation has not been comprehensively reviewed in over 2 decades. This narrative review summarizes the available literature on bone health in the context of lung transplantation,...
5.
Luong M, Nakamachi Y, Silveira F, Morrissey C, Danziger-Isakov L, Verschuuren E, et al.
Transpl Infect Dis . 2024 Feb; 26(3):e14251. PMID: 38351512
Purpose: Antimicrobial misuse contributes to antimicrobial resistance in thoracic transplant (TTx) and mechanical circulatory support (MCS) recipients. This study uses a modified Delphi method to define the expected appropriate antimicrobial...
6.
Alshehri M, Ramos K, Sykes J, Ma X, Stanojevic S, Quon B, et al.
Clin Transplant . 2023 Aug; 37(11):e15097. PMID: 37563332
Introduction: Re-transplant is an option for those who develop end-stage lung disease due to rejection; however, little data exist following re-transplantation in cystic fibrosis (CF). Methods: Data from the Canadian...
7.
Saddoughi S, Dunne B, Campo-Canaveral de la Cruz J, Lemaitre P, Diaz Martinez J, Martinu T, et al.
J Thorac Cardiovasc Surg . 2023 Aug; 167(3):861-868. PMID: 37541572
Objectives: To determine the impact of older donor age (70+ years) on long-term survival and freedom from chronic lung allograft dysfunction in lung transplant (LTx) recipients. Methods: A retrospective single-center...
8.
Wickerson L, Grewal R, Singer L, Chaparro C
Chron Respir Dis . 2023 Mar; 20:14799731221139293. PMID: 36987977
Background: Rehabilitation is prescribed to optimize fitness before lung transplantation (LTx) and facilitate post-transplant recovery. Individuals with cystic fibrosis (CF) may experience unique health issues that impact participation. Methods: Patient...
9.
McKone E, Ramos K, Chaparro C, Blatter J, Hachem R, Anstead M, et al.
J Cyst Fibros . 2023 Mar; 22(3):374-380. PMID: 36882349
There is no consensus on the best model of care for individuals with CF to manage the non-pulmonary complications that persist after lung transplant. The CF Foundation virtually convened a...
10.
Yu H, Kleiman V, Kojic K, Slepian P, Cortes H, McRae K, et al.
Transplantation . 2022 Dec; 107(6):1398-1405. PMID: 36482750
Background: With >700 transplant surgeries performed each year, Toronto General Hospital (TGH) is currently one of the largest adult transplant centers in North America. There is a lack of literature...